David A. Durden

2.4k total citations
78 papers, 1.9k citations indexed

About

David A. Durden is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Biochemistry. According to data from OpenAlex, David A. Durden has authored 78 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Cellular and Molecular Neuroscience, 24 papers in Molecular Biology and 18 papers in Biochemistry. Recurrent topics in David A. Durden's work include Amino Acid Enzymes and Metabolism (17 papers), Neurotransmitter Receptor Influence on Behavior (16 papers) and Neuroscience and Neuropharmacology Research (13 papers). David A. Durden is often cited by papers focused on Amino Acid Enzymes and Metabolism (17 papers), Neurotransmitter Receptor Influence on Behavior (16 papers) and Neuroscience and Neuropharmacology Research (13 papers). David A. Durden collaborates with scholars based in Canada, United Kingdom and India. David A. Durden's co-authors include Alan A. Boulton, Anthony Good, S. R. Philips, A. A. Boulton, Bárbara Davis, P. Kebarle, Bruce A. Davis, Lillian E. Dyck, Augusto V. Juorio and Peter H. Yu and has published in prestigious journals such as The Journal of Chemical Physics, Analytical Chemistry and Analytical Biochemistry.

In The Last Decade

David A. Durden

76 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David A. Durden Canada 23 558 504 466 184 164 78 1.9k
Ulrich Schmitt Germany 34 784 1.4× 834 1.7× 702 1.5× 43 0.2× 89 0.5× 119 3.8k
Karl H. Schram United States 28 162 0.3× 1.1k 2.1× 369 0.8× 203 1.1× 263 1.6× 91 2.3k
Klaus D. Haegele United States 26 264 0.5× 574 1.1× 619 1.3× 117 0.6× 205 1.3× 81 2.0k
Desmond O’Connor United Kingdom 25 386 0.7× 816 1.6× 462 1.0× 23 0.1× 443 2.7× 60 2.2k
Uwe J. Meierhenrich France 33 889 1.6× 798 1.6× 1.6k 3.4× 90 0.5× 287 1.8× 125 4.1k
W. C. Bowman United Kingdom 34 999 1.8× 1.7k 3.4× 134 0.3× 43 0.2× 240 1.5× 115 4.5k
Kenneth N.F. Shaw United States 25 228 0.4× 797 1.6× 322 0.7× 336 1.8× 237 1.4× 63 2.7k
Jean‐Jacques Filippi France 20 177 0.3× 367 0.7× 255 0.5× 80 0.4× 145 0.9× 50 1.3k
James A. Yergey United States 27 180 0.3× 728 1.4× 610 1.3× 187 1.0× 228 1.4× 65 2.5k
Yuichi Masuda Japan 33 493 0.9× 1.3k 2.5× 358 0.8× 55 0.3× 452 2.8× 215 4.1k

Countries citing papers authored by David A. Durden

Since Specialization
Citations

This map shows the geographic impact of David A. Durden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Durden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Durden more than expected).

Fields of papers citing papers by David A. Durden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Durden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Durden. The network helps show where David A. Durden may publish in the future.

Co-authorship network of co-authors of David A. Durden

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Durden. A scholar is included among the top collaborators of David A. Durden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Durden. David A. Durden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Durden, David A., et al.. (2010). Quantitation of fluoroquinolones in honey using tandem mass spectrometry (LC-MS/MS): nested validation with two mass spectrometers.. PubMed. 93(5). 1633–55. 11 indexed citations
2.
Boulton, Alan A., et al.. (1997). Aliphatic N-Methylpropargylamines: Monoamine Oxidase-B Inhibitors and Antiapoptotic Drugs. Advances in pharmacology. 42. 308–311. 14 indexed citations
3.
Paterson, I.A., Bárbara Davis, David A. Durden, et al.. (1995). Inhibition of MAO-B by (?)-deprenyl alters dopamine metabolism in the macaque (Macaca facicularis) brain. Neurochemical Research. 20(12). 1503–1510. 24 indexed citations
4.
5.
Milgram, Norton W., Gwen O. Ivy, Elizabeth Head, et al.. (1993). The effect ofl-deprenyl on behavior, cognitive function, and biogenic amines in the dog. Neurochemical Research. 18(12). 1211–1219. 36 indexed citations
6.
Dyck, Lillian E., et al.. (1993). Effects of monoamine oxidase inhibitors on the acid metabolites of some trace amines and of dopamine in the rat striatum. Biochemical Pharmacology. 45(6). 1317–1322. 9 indexed citations
7.
8.
Davis, Bruce A., Peter H. Yu, David A. Durden, et al.. (1991). Longitudinal study of inmates of a prison for the psychiatrically disturbed: Plasma concentrations of biogenic amine metabolites and amino acids. Psychiatry Research. 36(1). 85–97. 3 indexed citations
9.
Durden, David A., et al.. (1991). The effect of age, sex, weight and height on the plasma concentrations in healthy subjects of the acidic metabolites of some biogenic monoamines involved in psychiatric and neurological disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 15(4). 503–512. 10 indexed citations
10.
Davis, Bruce A., et al.. (1991). Phenylacetic acid in CSF and serum in Indian schizophrenic patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 15(1). 41–47. 14 indexed citations
11.
O’Reilly, Richard, et al.. (1991). Plasma phenylethylamine in schizophrenic patients. Biological Psychiatry. 30(2). 145–150. 27 indexed citations
12.
O’Reilly, Richard L., et al.. (1991). Effect of dietary phenylalanine on the plasma concentrations of phenylalanine, phenylethylamine and phenylacetic acid in healthy volunteers. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 15(5). 611–623. 9 indexed citations
13.
14.
Sloley, B.D., A. V. Juorio, & David A. Durden. (1990). High-performance liquid chromatographic analysis of monoamines and some of their?-glutamyl conjugates produced by the brain and other tissues ofHelix aspersa (gastropoda). Cellular and Molecular Neurobiology. 10(2). 175–192. 31 indexed citations
15.
Boulton, Alan A., et al.. (1989). Isolation, separation and analysis in neurochemistry: Trace amines and acids as an illustrative example. Journal of Chromatography B Biomedical Sciences and Applications. 488(1). 129–143. 2 indexed citations
16.
Durden, David A., Tommy Nguyen, & A. A. Boulton. (1988). Kinetics of intraventricularly injected trace amines and their deuterated isotopomers. Neurochemical Research. 13(10). 943–950. 7 indexed citations
17.
Dyck, Lillian E., A. V. Juorio, David A. Durden, & A. A. Boulton. (1988). Effect of chronic deuterated and non-deuterated phenelzine on rat brain monoamines and monoamine oxidase. Naunyn-Schmiedeberg s Archives of Pharmacology. 337(3). 279–83. 11 indexed citations
18.
Durden, David A. & A. A. Boulton. (1988). Analysis of tryptamine at the femtomole level in tissue using negative ion chemical ionization gas chromatography-mass spectrometry. Journal of Chromatography A. 440. 253–259. 9 indexed citations
19.
Bhave, Sanjiv V., S. D. Telang, David A. Durden, & A. V. Juorio. (1988). Effects of nutritional stress on brain tyramine concentration and dopamine turnover. Neurochemical Research. 13(6). 567–570. 2 indexed citations
20.
Durden, David A., et al.. (1986). Choice of analog electronic low-pass filters chromatography. Journal of Chromatography A. 368(1). 49–58. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ulrich Schmitt Breakdown of academic impact, for papers by Karl H. Schram Breakdown of academic impact, for papers by Klaus D. Haegele Breakdown of academic impact, for papers by Desmond O’Connor Breakdown of academic impact, for papers by Uwe J. Meierhenrich Breakdown of academic impact, for papers by W. C. Bowman Breakdown of academic impact, for papers by Kenneth N.F. Shaw Breakdown of academic impact, for papers by Jean‐Jacques Filippi Breakdown of academic impact, for papers by James A. Yergey Breakdown of academic impact, for papers by Yuichi Masuda
Rankless by CCL
2026